Barely Significant
← all excerpts

Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

J Clin Med · 2024 · PMC11242055 · PMID 38999529

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

nearly significantp = 0.06so close (0.05 < p ≤ 0.1)
Notably, the leukocyte count was also nearly significant (OR of 1.51 for any 1000/uL, CI95% 1.02–2.43, p = 0.06).

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.